SLAMF7-CAR T cell treatment of Multiple Myeloma patients

Different types of SLAM-specific immunotherapies. The figure shows

News CARAMBA

Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice - Parikh - 2023 - CA: A Cancer Journal for Clinicians - Wiley Online Library

Current Oncology, Free Full-Text

New clinical trial tests CAR T-cell therapy for multiple myeloma

PDF] Clinical potential of SLAMF7 antibodies – focus on elotuzumab in multiple myeloma

CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma

SLAMF7-CAR T cells eliminate myeloma and confer selective fratricide of SLAMF7+ normal lymphocytes - ScienceDirect

Cell-based immunotherapy approaches for multiple myeloma

Vaccines, Free Full-Text

Elotuzumab for the treatment of multiple myeloma, Journal of Hematology & Oncology

European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma

Full article: CAR T-Cell Therapy for Patients with Multiple Myeloma: Current Evidence and Challenges

Contemporary patient-tailored treatment strategies against high risk and relapsed or refractory multiple myeloma - eBioMedicine